Phase Ii Clinical Trial Of First-Line Combination Of Radiation Followed By Gemcitabine, Dexamethasone, And Cisplatin (Gdp) Chemotherapy For Early-Stage Extranodal Natural Killer/T-Cell Lymphoma With Unfavorable Prognostic Factors: The Green Study (Nct02276248).